CTNM 8-K 2026-07-13

Contineum Therapeutics, Inc. (CTNM) 8-K dated 2026-07-13 — accession 0001628280-26-048023. This URL is the filing, not the CTNM hub.

Contineum Therapeutics, Inc. (CTNM) is a biotechnology company listed on US.

Contineum Therapeutics, Inc. filed a 8-K on 2026-07-13. Accession 0001628280-26-048023.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.

Not investment advice. The CTNM SEC hub lists recent forms. The stock page is the research view.